Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Adrenocortical Hyperfunction

• Evaluate the Safety, Efficacy, and Pharmacokinetics of CRN04894 in Participants With Congenital Adrenal Hyperplasia
• Study to Determine the Prevalence of Hypercortisolism in Patients With Type 2 Diabetes and Treatment With Korlym® (Mifepristone) (CATALYST)
• Study of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia
• SPI-62 as a Treatment for Hypercortisolism Related to a Benign Adrenal Tumor
• SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's Syndrome
• Long-term Safety Study of Chronocort in the Treatment of Participants With Congenital Adrenal Hyperplasia
• A Phase 2 Study to Evaluate the Safety, PK, and Exploratory PD of Tildacerfont in Children With CAH
• Comparison of Chronocort Versus Standard Hydrocortisone Replacement Therapy in Participants Aged 16 Years and Over With Congenital Adrenal Hyperplasia
• Global Safety and Efficacy Registration Study of Crinecerfont in Pediatric Patients With Classic Congenital Adrenal Hyperplasia (CAHtalyst Pediatric Study)
• A Ph2b to Evaluate Tildacerfont in the Reduction of Glucocorticoid Steroid Doses in Adult CAH
• Global Safety and Efficacy Registration Study of Crinecerfont for Congenital Adrenal Hyperplasia
• A Ph2b to Evaluate Clinical Efficacy and Safety of Tildacerfont in Adult CAH
• Efficacy and Safety of Relacorilant in Patients With Cortisol-Secreting Adrenal Adenomas
• Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-74788 in Pediatric Subjects With Congenital Adrenal Hyperplasia
• Congenital Adrenal Hyperplasia Once Daily Hydrocortisone Treatment
• Subcutaneous Hydrocortisone Children With Congenital Adrenal Hyperplasia
• Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal Hyperplasia
• Nevanimibe HCl for the Treatment of Classic CAH
• Androgen Reduction in Congenital Adrenal Hyperplasia
• Open-label Comparison of Chronocort® Versus Standard Glucocorticoid Replacement Therapy
• Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-74788 in Adults With Congenital Adrenal Hyperplasia
• Study of SPR001 in Adults With Classic Congenital Adrenal Hyperplasia
• A Study of the Efficacy, Safety and Tolerability of Chronocort in Treating CAH
• A Study of ATR-101 for the Treatment of Congenital Adrenal Hyperplasia
• Comparison of Chronocort® With Standard Glucocorticoid Therapy in Patients With Congenital Adrenal Hyperplasia
• Androgen Reduction in Congenital Adrenal Hyperplasia, Phase 1
• Safety, Pharmacokinetics and Pharmacodynamics of NBI-77860 in Adolescent Females With Congenital Adrenal Hyperplasia
• Ultradian Subcutaneous Hydrocortisone Infusion in Addison Disease and Congenital Adrenal Hyperplasia
• Glucocorticoid Receptor Blockade With Mifepristone in Patients With Mild Adrenal Hypercortisolism
• Comparison of Cortisol Pump With Standard Treatment for Congenital Adrenal Hyperplasia
• Continuous Subcutaneous Hydrocortisone Infusion in Congenital Adrenal Hyperplasia
• Pilot Study to Characterize and Examine the Pharmacokinetics and Efficacy of Chronocort® in Adults With CAH
• A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia
• Dexamethasone Treatment of Congenital Adrenal Hyperplasia
• Research Study for Children With Salt Wasting Congenital Adrenal Hyperplasia
• Comparison of Two Forms of Hydrocortisone in Patients With Congenital Adrenal Hyperplasia
• Effects of Pioglitazone in Congenital Adrenal Hyperplasia
• Three Drug Combination Therapy Versus Conventional Treatment of Children With Congenital Adrenal Hyperplasia
• Dose Response Relationship for Single Doses of Corticotropin Releasing Hormone (CRH) in Normal Volunteers and in Patients With Adrenal Insufficiency
• Congenital Adrenal Hyperplasia: Calcium Channels as Therapeutic Targets